Leap Therapeutics's total assets for Q3 2025 were $11.40M, a decrease of -43.12% from the previous quarter. LPTX total liabilities were $8.70M for the fiscal quarter, a -39.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.